Search Results - "Capra, Marcello"
-
1
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
Published in Haematologica (Roma) (01-01-2011)“…Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has…”
Get full text
Journal Article -
2
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection
Published in Haematologica (Roma) (01-05-2012)“…Polymorphisms in the interleukin-28B are important determinants in the spontaneous and drug-induced control of hepatitis C virus infection. We assessed the…”
Get full text
Journal Article -
3
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients
Published in Journal of cardiovascular medicine (Hagerstown, Md.) (01-10-2015)“…AIMSOur aim was to evaluate the correlation between myocardial fibrosis detected using the late gadolinium enhancement (LGE) cardiovascular magnetic resonance…”
Get full text
Journal Article -
4
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C
Published in Haematologica (Roma) (01-08-2008)“…1 Unità Complessa di Gastroenterologia ed Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.MI.S.), University of Palermo 2 Unità…”
Get full text
Journal Article -
5
Design of hydrogen production systems powered by solar and wind energy: An insight into the optimal size ratios
Published in Energy conversion and management (15-08-2024)“…[Display omitted] •Optimal design of power-to-hydrogen systems fed by renewable energy sources.•Size ratios are explored for different plant configurations…”
Get full text
Journal Article -
6
A T2 MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
Published in Journal of cardiovascular magnetic resonance (02-02-2011)“…Figure 1 [figure omitted; refer to PDF] Conclusions Prospectively over 15 months in a large clinical setting of TM patients DFP monotherapy was significantly…”
Get full text
Journal Article -
7
The Management of Iron Chelation Therapy: Preliminary Data from a National Registry of Thalassaemic Patients
Published in Anemia (01-01-2011)“…Thalassaemia and other haemoglobinopathies constitute an important health problem in Mediterranean countries, placing a tremendous emotional, psychological,…”
Get full text
Journal Article -
8
A T2 MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
Published in Journal of cardiovascular magnetic resonance (02-02-2011)“…Meeting abstracts - A single PDF containing all abstracts in this supplement is available at…”
Get full text
Journal Article -
9
A T2 MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
Published in Journal of cardiovascular magnetic resonance (02-02-2011)“…Meeting abstracts - A single PDF containing all abstracts in this supplement is available at…”
Get full text
Journal Article -
10
-
11
Influence of myocardial fibrosis and blood oxygenation on heart T2 values in thalassemia patients
Published in Journal of magnetic resonance imaging (01-04-2009)“…Purpose To determine whether T2* measurements quantifying myocardial iron overload in thalassemia patients are influenced by myocardial fibrosis and blood…”
Get full text
Journal Article -
12
-
13
-
14
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
Published in Blood (28-07-2011)“…Patients with β-thalassemia require lifelong iron chelation therapy from early childhood to prevent complications associated with transfusional iron overload…”
Get full text
Journal Article -
15
Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
Published in British journal of haematology (01-10-2014)“…Summary The risk of developing hepatocellular carcinoma (HCC) in patients with thalassaemia is increased by transfusion‐transmitted infections and…”
Get full text
Journal Article -
16
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
Published in Blood (01-05-2006)“…Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3…”
Get full text
Journal Article -
17
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition
Published in British journal of haematology (01-02-2010)“…Summary The correlation between liver stiffness, measured by transient elastography, liver fibrosis, using the histological METAVIR score, and iron overload,…”
Get full text
Journal Article -
18
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel
Published in Blood (21-10-2010)“…Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia patients. Liver diseases have emerged as a critical clinical…”
Get full text
Journal Article -
19
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
Published in Blood cells, molecules, & diseases (01-05-2009)“…The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop…”
Get full text
Journal Article -
20
Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
Published in British journal of haematology (01-04-2009)“…Summary A multicentre randomized open‐label trial was designed to assess the effectiveness of long‐term sequential deferiprone–deferoxamine (DFO–DFP) versus…”
Get full text
Journal Article